FHIT基因与妇科肿瘤的研究进展
摘要
脆性组氨酸三联体基因(FHIT)是定位于染色体3p14.2的抑癌基因,在细胞凋亡和细胞周期调控中发挥重要作用,通过细胞素信号传递系统、微管系统等多种途径发挥抑癌作用,其异常表达在癌组织中广泛存在,为研究妇科肿瘤的发病机制提供了新的线索。
出处
《国外医学（妇产科学分册）》
2004年第2期107-109,共3页
Foreign Medical Sciences(Obstet Gynecol Fascicle)
参考文献19
-
1Ohta M ,Inoue H,Grazia M, et al.The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint, is abnormal in digestive tract cancers. Cell,1996,84:587-597.
-
2Sard L, Aeeornero P, Tornielli S,et al. The tumor-suppressor gene FH1T is involved in the regulation of apoptosis and in eell eyele control. Proc Natl Aead Sei USA, 1999, 96:8489-8492.
-
3Roz L, Gramegna M, Ishii H,et al. Restoration of fragile histidine triad (FH1T) expression induces apoptosis and suppress tumorigenicity in lung and cervical cancer cell lines. Proc Natl Acad Sci USA,2002, 99:3615 -3620.
-
4Shi Y, Zou M, Farid NR, et al. Association of FHIT (fragile histidine triad ), a candidate tumor suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem J, 2000,352:443-448.
-
5Chaudhuri AR, Khan IA, Prasad V, et al. The tumor suppressor protein tlait. J Biol Chem, 1999,274:24378-24382.
-
6Helland A, Kraggerud SM, Kristensen GB, et al. Primary cervical carcinomas show 2 common regions of deletion at 3p, l within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in rela-tion to survival. Int J Cancer, 2000,88:217-222.
-
7Yoshino K, Enomoto T, Nakamura T, et al. FH1T alterations in cancerous and non-cancerous cervical epithelium. Int J Cancer, 2000,85:6-13.
-
8lshii H , Dumon KR, Vecchione A, et al. Potential cancer therapy with the fragile histidine triad gene .JAMA,2001,286:2441-2449.
-
9Butler D, Sc M, Collins C, et al. Loss of FH1T expression as a potential marker of malignant progression in preinvasive squamous cervical canser. Gynecol Oncol, 2002,86:144-149.
-
10Vecchione A, Zanesi N, Trombetta G, et al. Cervical dysplasia,ploidy, and human papillomavirus statis correlate with loss of Fhit expression. Clin Cancer Res, 2001,7:1306-1312.
-
1贝春花.胸腺细胞素治疗肿瘤的临床观察[J].中国药业,1997,6(3):38-38. 被引量：1
-
2刘峰,吴军正.头颈部肿瘤中FHIT基因的研究[J].临床口腔医学杂志,2002(z1):124-125.
-
3邓燕飞,卢永德.FHIT基因与头颈肿瘤[J].国外医学（耳鼻咽喉科学分册）,2000,24(4):228-231.
-
4尹晓庆,赖玉书,顾新.FHIT与肝癌关系的研究进展[J].内蒙古医学杂志,2007,39(5):534-536. 被引量：1
-
5杨振华,吴军华,朱莉萍,朱莉杰.细胞周期素与卵巢癌关系的研究进展[J].中国社区医师（医学专业）,2012,14(14):5-5. 被引量：1
-
6张荣河,何三光.细胞素及合用异博定对人乳腺癌细胞多药耐药性逆转作用的研究[J].中华实验外科杂志,2000,17(2):190-190. 被引量：1
-
7张宏.胃癌组织中细胞素D_1的表达与胃癌分化程度及预后关系的探讨[J].疾病监测与控制,2017,11(2):116-117.
-
8张敏,张新,白春学.表皮生长因子受体与酪氨酸激酶抑制剂在肿瘤防治中的应用进展[J].中国癌症杂志,2003,13(3):275-278. 被引量：18
-
9张燕子,王小平.脆性组氨酸三联体基因在肺癌发病中的研究进展[J].社区医学杂志,2009,7(3):35-37.
-
10冯广加,何莲芝.VEGF-C及VEGFR-3在宫颈癌组织中的表达及其意义[J].皖南医学院学报,2007,26(4):267-269. 被引量：5
